qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial Background: Sepsis guidelines suggest immediate start of resuscitation for patients with quick Sequential Organ [...]

The role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta-analysis This meta-analysis focuses on identifying the impact of [...]

Soluble Urokinase-Type Plasminogen Activator Receptor as a Prognostic Marker of Ugandan Children at Risk of Severe and Fatal Malaria Background: Current malaria diagnostic tests do not reliably identify children at risk of severe and fatal [...]

2023 yielded many interesting and important studies about suPAR, here is a recap of the most impactful ones An increasing number of suPAR studies highlights its growing importance in healthcare and proves suPAR's versatility and [...]

Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis Background: Numerous observational studies and clinical trials have [...]

Social isolation, loneliness, and inflammation: A multi-cohort investigation in early and mid-adulthood Background: A meta-analysis reveals a 25–30% increased risk of mortality associated with social isolation, loneliness, and living alone (Holt-Lunstad et al., 2015). According [...]

suPARnostic®: an advanced predictive tool for detecting recurrence in renal cell carcinoma Background: Plasma soluble urokinase-type Plasminogen Activator Receptor (suPAR) predicts disease aggressiveness in renal cell carcinoma (ccRCC), but its prognostic accuracy has not been [...]